Oral epithelial cells discriminate between pathogenic and non-pathogenic stimuli, and only induce an inflammatory response when they are exposed to high levels of a potentially harmful microorganism. The pattern recognition receptors (PRRs) in epithelial cells that mediate this differential response are poorly understood. Here, we demonstrate that the ephrin type-A receptor 2 (EphA2) is an oral epithelial cell PRR that binds to exposed β-glucans on the surface of the fungal pathogen Candida albicans. Binding of C. albicans to EphA2 on oral epithelial cells activates signal transducer and activator of transcription 3 (Stat3) and mitogen-activated protein kinase signaling in an inoculum-dependent manner, and is required for induction of a pro-inflammatory and antifungal response. Inhibition of EphA2 in mice decreases IL-17 signaling during oropharyngeal candidiasis, resulting in increased oral fungal burden and fungal dissemination. Our study reveals that EphA2 functions as PRR for β-glucans that senses epithelial cell fungal burden and is required for the maximal mucosal inflammatory response to C. albicans.
Oral epithelial cells are continuously exposed to a multitude of antigens derived from food and the resident bacterial and fungal microbiota. They must be able to discriminate between pathogenic and non-pathogenic stimuli so that an inflammatory response is induced only when the epithelial cells are exposed to high levels of a potentially harmful microorganism.
The interactions of oral epithelial cells with the fungus Candida albicans provides an example of this paradigm. As part of the normal microbiota of the gastrointestinal and reproductive tracts of healthy individuals (1) , this organism elicits a minimal epithelial cell response during commensal growth, when a low number of organisms is present. However, when local or systemic host defenses are weakened, C. albicans can proliferate and cause oropharyngeal candidiasis (OPC), an infection that is highly prevalent in patients with HIV/AIDS, diabetes, and iatrogenic or autoimmune-induced dry mouth (2) . When OPC occurs, oral epithelial cells are activated to induce a pro-inflammatory response that plays a central role in limiting the extent of infection.
For example, mice with an oral epithelial cell-specific defect in IL-17 receptor signaling or production of β defensin 3 are highly susceptible to OPC and unable to resolve the infection (3) .
How oral epithelial cells discriminate between C. albicans when it grows as a commensal organism versus an invasive pathogen is incompletely understood. The fungus can interconvert between ovoid yeast and filamentous hyphae. C. albicans yeast are poorly invasive and weakly stimulate epithelial cells to release proinflammatory cytokines and host defense peptides (HDPs).
In contrast, hyphae avidly invade epithelial cells and strongly stimulate the production of cytokines and HDPs (4) (5) (6) . Mucosal epithelial cells express a variety of pattern recognition receptors (PRRs) that can potentially recognize C. albicans (7) . These cells also express nonclassical receptors such as the epidermal growth factor receptor (EGFR), HER2, and E-cadherin that can recognize C. albicans hyphae (8) (9) (10) . However, relatively little is known about PRRs in oral epithelial cells, even though these cells constitute a key barrier to mucosal infection.
The ephrin type A receptor 2 (EphA2) is a receptor tyrosine kinase that induces both endocytosis and cytokine production by host cells (11, 12) . We investigated the hypothesis that EphA2 functions as an epithelial cell receptor for C. albicans. By confocal microscopic imaging of intact epithelial cells infected with C. albicans, we observed that EphA2 accumulated around yeast-phase cells after 15 min of infection and hyphae after 90 min (Fig. 1A) . To ascertain whether C. albicans activated EphA2, oral epithelial cells were infected with yeast-phase C. albicans cells and the extent of EphA2 autophosphorylation was analyzed over time. EphA2 phosphorylation increased above basal levels within 15 min post-infection, when the organisms were still in the yeast phase ( Fig. 1B; S1 ). EphA2 phosphorylation also remained elevated after 60 and 90 min of infection, when the organisms had formed hyphae. When epithelial cells were incubated for 15 min with either yeast-or hyphal-phase organisms, Epha2 phosphorylation was stimulated to the same extent, indicating that both forms of the organism can activate the receptor (Fig. 1C , S1).
To determine the specificity of EphA2 signaling, we analyzed whether bacteria (Staphylococcus aureus, Escherichia coli), a clinical mucosal C. albicans isolate (529L), a yeastlocked C. albicans mutant (efg1/cph1), and different fungal species (Candida glabrata, Saccharomyces cerevisiae) were able to induce EphA2 phosphorylation. Although neither S. aureus nor E. coli stimulated the phosphorylation of EphA2 (Fig. S2 ), all fungi tested induced phosphorylation of this receptor within 15 min of infection ( Fig. 1D, S3 ), suggesting that EphA2 is activated by a conserved fungal cell wall component. To test this possibility, we analyzed EphA2 activation by β-glucan and mannan, which are present in the cell walls of many fungi. Both particulate β-glucan (zymosan) and soluble β-glucan (laminarin) stimulated EphA2 phosphorylation after 15 and 30 min, and this phosphorylation returned to basal levels by 60 min (Fig. 1E , F, S4).
Mannan, another cell wall component, failed to induce detectable EphA2 phosphorylation ( Fig. S5 ).
To ascertain whether EphA2 interacts directly with β-glucans, we used an ELISA to analyze the binding of recombinant EphA2 to potential ligands. As expected, EphA2 bound with high affinity to its natural ligand, ephrin A1 (EFNA1) (Fig. 1G ). EphA2 also bound avidly to zymosan and laminarin, but not to mannan in both the presence and absence of 10 mM EDTA, indicating that binding to β-glucans is independent of Ca 2+ . Consistent with the ELISA data, we found that recombinant EphA2 bound to intact yeast-phase C. albicans cells at regions of exposed β-glucan, as demonstrated by co-localization with dectin-1-Fc ( Fig. 1H ). EphA2 also bound to exposed β-glucan on other fungal pathogens, including Aspergillus fumigatus and Rhizopus delemar ( Fig. S6 ).
C. albicans hyphae can invade oral epithelial cells by receptor-induced endocytosis (10), and epithelial cell invasion is associated with fungal-induced epithelial cell damage (6) . We analyzed the effects of the small molecule tyrosine kinase inhibitor, dasatinib (DAS) (13) , and a specific EphA2 antagonist, 4-(2,5-dimethyl-1H-pyrrol-1-yl)-2-hydroxybenzoic acid (ANT) (14) on C. albicans invasion and damage of epithelial cells to determine the biological significance of EphA2 activation. After verifying that DAS and ANT inhibited C. albicans-induced phosphorylation of EphA2 ( Fig. S7 ), we found that both inhibitors significantly reduced endocytosis of C. albicans ( Fig.   2A ) and host cell damage ( Fig. 2B ), but had no effect on C. albicans growth rate or hyphal elongation (Table S1 ). Depletion of epithelial cell EphA2 by siRNA similarly inhibited fungal endocytosis and host cell damage ( Fig. S8 ), while addition of EFNA1 to further stimulate EphA2 enhanced both invasion and damage ( Fig. 2A, B) . Thus, the extent EphA2 activation governs epithelial cell endocytosis of C. albicans and subsequent fungal-induced damage.
Epidermal growth factor receptor (EGFR) signaling is crucial for inducing the endocytosis of C. albicans by oral epithelial cells (8, 15) . We analyzed the relationship between EGFR and EphA2 signaling during the endocytosis of C. albicans and found that inhibition of EphA2 with either DAS or ANT, and inhibition of EGFR with gefitinib (8) reduced the endocytosis of C. albicans by a similar amount (Fig. 2C ). Simultaneous inhibition of both EphA2 and EGFR did not decrease endocytosis further. Also, inhibition of EphA2 with DAS or ANT blocked C. albicans-induced EGFR phosphorylation ( Fig. S9 ). Collectively, these results suggest that EphA2 and EGFR function in the same pathway and that EphA2 activation is required for induction of EGFR signaling and subsequent endocytosis of C. albicans.
Contact with C. albicans yeast cells activates multiple signaling pathways in oral epithelial cells including mitogen-activated kinase regulated kinase (MEK) 1/2, p38, and NF-κB (16) . We investigated whether EphA2 might function as a receptor that activates these signaling pathways. We determined that C. albicans stimulated the phosphorylation of MEK1/2 and p38-mediated phosphorylation of the c-Fos transcription factor within 30 min of infection ( Fig. 2D and S10). The phosphorylation of these proteins was maintained for at least 90 min and was inhibited by both DAS and ANT. Although C. albicans stimulated phosphorylation of the p65 subunit of NF-κB, this phosphorylation was not inhibited by DAS or ANT, suggesting that NF-κB activation is induced by a receptor other than EphA2. One candidate receptor is the dectin-1 β-glucan receptor, which we determined was expressed on the surface of both the OKF6/TERT-2 oral epithelial cell line and desquamated human buccal epithelial cells ( Fig. S11 ). We found that a neutralizing dectin-1 mAb inhibited C. albicans-induced activation of p65 ( Fig. 2 E, S12), but had no effect on the phosphorylation of EphA2 (S13). These results suggest that in response to C. albicans infection, dectin-1 is necessary for induction of NF-κB signaling in oral epithelial cells, whereas EphA2 is required for activation of the MEK1/2 and p38 signaling pathways.
To investigate EphA2 signaling induced by β-glucan alone, we analyzed the response of epithelial cells to zymosan. While zymosan strongly activated MEK1/2 phosphorylation at 15 and 30 min, phosphorylation returned to basal levels by 60 min (Fig. S14 ). Also, zymosan did not induce detectable c-Fos phosphorylation over the 90-min duration of the experiment (Fig. S12 ). Thus, fungal factors in addition to β-glucan are required to sustain MEK1/2 signaling and induce c-Fos phosphorylation.
By secreting proinflammatory cytokines and host defense peptides (HDPs), oral epithelial cells are vital for limiting fungal proliferation during OPC (17, 18) . The production of many of these factors is governed by the transcription factor signal transducer and activator of transcription 3 (STAT3) (17, 19) . We hypothesized that the interaction of C. albicans with EphA2 in oral epithelial cells would activate Stat3 and stimulate production of proinflammatory cytokines and HDPs. To test this, we determined the effects of DAS and ANT on Stat3 phosphorylation in epithelial cells. By both immunoblotting and ELISA, we found that C. albicans stimulated Stat3 phosphorylation within 15 min of infection and that blocking EphA2 with DAS or ANT reduced C. albicans-induced Stat3 phosphorylation to basal levels ( Fig. 3A , B, S15). Depletion of EphA2 in oral epithelial cells with siRNA also decreased C. albicans-induced Stat3 phosphorylation ( Fig. S15 ). Although exposure to zymosan induced Stat3 phosphorylation within 15 min, this phosphorylation was transient, returning to basal levels after 30 min ( Fig. 3C , S15). Inhibition of dectin-1 did not reduce zymosan-induced activation of Stat3 ( Fig. S16 ), suggesting that EphA2 is the primary β-glucan receptor that activates this transcription factor.
By blocking EphA2 signaling with DAS, ANT or the Stat3 inhibitor S31-201 (20) , we found that the EphA2-Stat3 axis regulates C. albicans-induced mRNA expression of the chemokines Ccl20 and Ccl3, and the alarmin S100a8 in vitro (Fig. 3D ). It also governs the secretion of human βdefensin 2 (hBD2) ( Fig. 3E and S17). Although EphA2 inhibition reduced Il8 mRNA expression and secretion of IL-8, IL-1α and IL-1β, inhibition of Stat3 did not ( Fig. 3D, E) . Thus, these responses are induced by EphA independently of Stat3. Treatment of epithelial cells with DAS or ANT did not inhibit production of IL-8 induced by TNF-α and IL-17 ( Fig. S18 ), indicating that these inhibitors had no effect on the epithelial cell response to a stimulus other than β-glucan.
The addition of zymosan to the epithelial cells did not stimulate secretion of IL-8 or hBD2 ( Fig. S19 ), suggesting that although β-glucan-induced EphA2 activation is required to prime epithelial cells, a second signal is necessary to prolong EphA2 activation and stimulate cytokine and HDP release. Dectin-1, another β-glucan receptor (21, 22) , played limited role in the epithelial cell response to C. albicans; an anti-dectin-1 antibody had no effect on the release of hBD2, IL-1α, or IL-1β by infected epithelial cells, although it did cause a modest reduction in IL-8 release ( Fig. 3E ).
We investigated whether the extent of EphA2 activation governed the epithelial cell response to infection with different inocula of C. albicans. We found that while there was a gradual increase in the extent of EphA2 phosphorylation as the multiplicity of infection (MOI) increased from 0.1 to 5 organisms per epithelial cell, EphA2 phosphorylation dramatically increased at a MOI of 10 ( Fig. 3F,   S18 ). Low level phosphorylation of MEK1/2 was also stimulated by C. albicans yeast at a MOI of 0.1 to 1, whereas phosphorylation increased exponentially at MOIs of 5 and 10 ( Fig. 3F , S18). (Fig. S18 ). The increased phosphorylation of EphA2 and MEK1/2 at high MOIs corresponded to enhanced secretion of IL-8 and hBD2 (Fig. 3H, I) . Thus, while low inocula of C. albicans induce modest EphA2 activation and a minimal inflammatory response, higher inocula highly activate EphA2, leading to a strong inflammatory response.
Phosphorylation of Epha2 was blocked by DAS and ANT at all MOIs
To determine the biological significance of EphA2 as a β-glucan receptor for C. albicans in vivo, we tested the effects of DAS in the corticosteroid-treated mouse model of OPC (23) . Mice that received DAS had increased severity of infection, as manifested by greater weight loss and higher oral fungal burden relative to the animals that received the vehicle control ( Fig. 4A, B ).
Histopathological analysis of the tongues of DAS-treated mice confirmed that inhibition of EphA2 signaling resulted in larger fungal lesions and deeper tissue invasion ( Fig. S19 ). Mice treated with DAS also had greater fungal dissemination to the liver, suggesting that EphA2 is required for maintaining the epithelial barrier function of the GI tract ( Fig. 4C ). Consistent with our in vitro results, we found that C. albicans infection of the vehicle control mice induced strong Stat3 phosphorylation in the oral epithelium, and this phosphorylation was reduced by treatment with DAS ( Fig. S20 ). Administration of DAS also reduced Il17a mRNA expression in the oral tissues by 350fold, Il22 mRNA by 1000-fold, S100a8 mRNA by 9-fold and Defb3 mRNA by 7-fold, suggesting that EphA2 signaling is necessary for a maximal IL-17/IL-22 response (Fig. 4D ). Thus, EphA2 is a key regulator of the host inflammatory response to C. albicans that limits fungal proliferation during oral infection.
The data presented herein indicate that EphA2 is a non-classical receptor for β-glucans that plays a vital role in sensing the presence of C. albicans yeast and hyphae in the oral cavity.
While EphA2 contributes to receptor-induced endocytosis of the organism, this function is overshadowed by the central role of EphA2 in sensing the presence of high levels of fungal βglucans, activating MAPKs and Stat3, and thereby stimulating epithelial cells to produce proinflammatory cytokines and HDPs. In vivo, β-glucan recognition of invading fungi via EphA2 is also required for the production of IL-17, IL-22, and β defensin 3, which are essential for resistance to OPC (18, 24, 25) . Thus, our data support the model that EphA2 recognizes βglucans expressed by pathogenic fungi and thereby primes epithelial cells to respond appropriately and prevent OPC when the fungal inoculum increases above threshold levels ( Fig.   S21 ). Statistical analysis of binding is shown relative to wells coated with BSA. EFNA1, ephrin A1; lam, laminarin; man, mannan; zym, zymosan (H) EphA2 (red) and dectin-1-Fc (green) bind to exposed βglucan on yeast-phase C. albicans organism. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; NS, not significant. Scale bars 5 µm. As described previously (7) , siRNA was used to deplete EphA2 from the epithelial cells.
OKF6/TERT-2 cells were transfected with random control siRNA or EphA2 siRNA (80 pmol; Santa Cruz Biotechnology) using Lipofectamine 2000 (Thermo Fisher Scientific) following the manufacturer's instructions.
Confocal Microscopy. The accumulation of EphA2 around C. albicans was visualized using a minor modification of our previously described methods (1) . Oral epithelial cells were infected with 2 × 10 5 yeast organims of a wild-type C. albicans strain expressing GFP. After 15, and 90 min, the cells were fixed in 3% paraformaldehyde (wt/vol), blocked with 10% BSA (vol/vol), and incubated with antibodies against total EphA2, Stat3, or C. albicnas (9) followed by the appropriate secondary antibodies that had been labeled with either AlexaFluor 488 or AlexaFluor 568. The cells, or OCT sections, were then imaged by confocal microscopy, and the final images were generated by stacking optical sections along the z axis. Detection of Phosphorylation. OKF6/TERT-2 cells in 24-well tissue culture plates were infected with 1 × 10 6 C. albicans for various times. Next, the cells were rinsed with cold HBSS containing protease and phosphatase inhibitors and removed from the plate with a cell scraper.
The cells were collected by centrifugation and boiled in sample buffer. The lysates were separated by SDS/PAGE, and the phosphorylated proteins were detected by immunoblotting with phospho-specific antibodies. The blots were then stripped, and total protein levels and β-actin were detected by immunoblotting.
Stat3 ELISA. To quantify the phosphorylation of Stat3, OKF6/TERT-2 cells in 96-well tissue culture plates were treated with inhibitors for 1 h and then infected with 3 × 10 5 C.
albicans cells for different time periods. Next the epithelial cells were permeabilized and the phosphorylation of Stat3 was measured by an ELISA for phosph-Ser727 (LSBio) following the manufacturer's instructions.
Measurement of Host Cell Endocytosis.
The endocytosis of C. albicans by oral epithelial cells was quantified as described previously (1) . OKF6/TERT-2 cells were grown to confluency on fibronectin-coated circular glass coverslips in 24-well tissue culture plates. They were infected with either 2 × 10 5 yeast-phase C. albicans cells per well for 120 min. To determine the effects of the inhibitors on endocytosis, the host cells were incubated with indicated inhibitors as described above. Control cells were incubated in a similar concentration of diluent (0.25% DMSO). The inhibitors were added to the host cells 60 min before the fungal cells, and they remained in the medium for the entire incubation period.
Host cell damage assay. The extent of host cell damage caused by the C. albicans was measured using a standard 51 Cr release assay (1, 10) . Briefly, OKF6/TERT-2 were grown to confluence in 96-well tissue culture plates, loaded with 51 Cr overnight, and then infected with 3 × 10 5 cells of the C. albicans. Parallel wells were left uninfected as a negative control. After an 8h incubation, the amount of 51 Cr that had been released into the medium and that remained associated with the cells was measured. To determine the effects of the inhibitors on cell damage, the host cells were incubated with 2.5 µM dasatinib or 400 µM EphA2 antagonist.
Control cells were incubated in a similar concentration of diluent (0.25% DMSO). Each experiment was performed three times in triplicate.
RNA isolation and RT-PCR.
Total RNA was isolated and RT-PCR was performed as previously described (11) . For RT-PCR host RNA was extracted using the Ribopure Yeast Kit (Life Technologies), according to the manufacturer's instructions. The mRNA levels of were measured by real-time PCR using the primers listed in Table S3 in the supplemental material.
The relative transcript level of each gene was normalized to GAPDH by the 2 -ΔΔCT method.
Measurement of hBD2 expression.
To determine hBD2 expression in OKF6/TERT-2 cells peptide secretion was performed following the manufacturer's instructions. Briefly, OKF6/TERT-2 cells in 24-well tissue culture plates were pre-treatment of inhibitors following infection with 1 × 10 6 C. albicans for 20 hours. The supernatant was collected and hBD2 secretion was determined by ELISA.
IL-8 Elisa.
To determine IL-8 release of OKF6/TERT-2 cells supernatants were collected and ELISA was determined following manufators instructions (R&D Systems).
Cytokine array. Cytokine levels in culture supernatants were determine as previously described (12) . Briefly OKF6/TERT-2 cells were infected with C. albicans in a 96-well plate (MOI 5). After 8 h infection, the supernatant was collected, clarified by centrifugation and stored in aliquots at −80 °C. The concentration of IL-1α, IL-1β, and IL-8/CXCL8 in the medium was determined using the Luminex multipex assay (R&D Systems). Each condition was tested in three independent experiments.
EphA2-binding ELISA. 50 µg carbohydrates (laminarin, zymosan, or mannan), 2 µg EFNA1 (positive control), or 50 µg BSA were coated ON at 20 °C in 96-well plates, blocked with non-fat dry milk for 1 hour. After washing 100 µg/mL recombinant EphA2 (Gln25-Asn534-6xHis; BioLegend) was added to each well and incubated for 2 hours at 37 °C. Washing was repeated and 1 µg/mL anti-His-HRP mAb was added and incubated for 1 hour at 37 °C.
Washing was repeated and color reagent was added following the manufacturer's instructions (R&D Systems). After 5 min stop solution was added and values were read at 450 nm.
Mouse model of oropharyngeal candidiasis. The effect of DAS on the severity of OPC
was determined using a mouse model of oropharyngeal candidiasis (13) . Male BALB/C mice were fed an oral solution of dasatinib (10mg/kg/day), twice a day, administered at 0.05 ml/ dose starting on day −1 relative to infection. Triamcinolone (15 mg/kg) was administered s.c. on days −1, 1, and 3 (13) . For inoculation, the mice were sedated, and a swab saturated with 10 6 C. albicans cells was placed sublingually for 75 min; 4 d later, the mice were euthanized, and their tongue and attached tissues were harvested and divided by two. One-half was weighed, homogenized, and quantitatively cultured. The other one-half was snap frozen in Optimal Cutting Temperature (OCT); 2 μm-thick sections were cut with a cryostat and fixed with cold acetone. To detect phosphorylation of Stat3, the cryosections were rehydrated in PBS and then blocked with 10 % BSA. Sections were stained with P-Stat3 Ab (Cell Signaling), primary antibodies rinsed, and stained with an AlexaFluor 488 secondary antibody followed by anti- 
